Articles tagged "Polyma virus"

2019 American Transplant Congress
Increasing Net Immunosuppression after BK Viremia
L. Cotiguala, A. Masood, J. Park, A. Naik
University of Michigan, Ann Arbor, MI
*Purpose: BK viremia is associated with inferior kidney allograft outcomes. Typical treatment involves reduction in immunosuppression. However reduction in immunosuppression is also likely to lead…
2019 American Transplant Congress
Low Specific Gravity Of First Morning Urine Predicts Bkvn in Kidney Transplant Recipients With Bk Viruria
G. Huang¹, X. Chen¹, Z. Wang², Y. Nuertai², W. Chen³, S. Yang³, P. Chen⁴, C. Wang¹
¹Organ Transplant Center, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ²Department of Clinical Medicine, Sun Yat-sen University Zhongshan School of Medicine, Guangzhou, China, ³Department of Pathology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China, ⁴Department of Clinical Laboratory, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, China
*Purpose: BK Polyomavirus nephropathy (BKVN) is an important cause of dysfunction and failure of renal transplants. BKV usually infects urinary tract retrogradely. The collecting duct…
2019 American Transplant Congress
The Association Of Frailty With Risk Of Cytomegalovirus And BK Infection
J. Norman¹, A. Gupta², A. Naik³, D. Cibrik², S. Norman³
¹Internal Medicine, Univ of Michigan Medical Ctr, Ann Arbor, MI, ²Internal Medicine/Nephrology, Kansas University Medical Center, Kansas City, KS, ³Internal Medicine/Nephrology, Univ of Michigan Medical Ctr, Ann Arbor, MI
*Purpose: Opportunistic infections are responsible for significant morbidity and mortality post-kidney transplant (KT). Recently, medical frailty has been recognized to increase the risk of death…
2019 American Transplant Congress
Protocol Cidofovir for Refractory Polyomavirus Associated Nephropathy in Kidney Transplant Recipients
J. Clark, A. Haririan
University of Maryland Medical Center, Baltimore, MD
*Purpose: Dose-limiting nephrotoxicity has historically precluded the use of cidofovir for polyomavirus associated nephropathy (PVAN). With incidence of BK viremia in kidney transplant recipients increasing…
2019 American Transplant Congress
Evaluation of Infection and Renal Transplant Outcomes in the Hmong Population
M. Jorgenson¹, J. Descourouez¹, D. Yang², G. Leverson², J. Smith², R. Redfield²
¹UW Health, Madison, WI, ²University of Wisconsin School of Medicine and Public Health, Madison, WI
*Purpose: Literature suggests the Hmong people to be at higher risk for infection, particularly fungal. The risk of infection after transplant in the Hmong population…
2019 American Transplant Congress
Are Ureteric Stents a Risk Factor for Bk Virus Activation in Kidney Transplantation?
L. Tran, R. Akiki, A. Gautam
Surgery- Section of Transplant Surgery, Boston University School of Medicine, Boston, MA
*Purpose: Ureteric stents are used in Kidney Transplantation, to reduce the incidence of ureteric leaks. There have been a few studies suggesting that placement of…
2019 American Transplant Congress
The Crucial Role of Molecular Microscope in the Interpretation of Ambiguous Lesions Such as Banff Borderline Changes and Tubulo-Interstitial Inflammation Accompanying PVAN
D. Deborska-Materkowska¹, A. Perkowska-Ptasinska¹, M. Ciszek¹, P. F. Halloran², M. Myslak³
¹Warsaw Medical University, Warsaw, Poland, ²ATAGC, University of Alberta, Edmonton AB, AB, Canada, ³Pomeranian Medical University, Szczecin, Poland
*Purpose: Anti-rejection treatment implementation is highly dependent on morphologic lesions interpretation based on Banff classification. Unfortunately, some light microscopic phenotypes are ambiguous which constricts the…
2019 American Transplant Congress
BK Virus Infection among Kidney Transplant Recipients with High Immunological Risk and Strong Immunosupression
G. Ledesma, M. O. Lopez, G. Carreño, M. J. Santana, M. A. Vaca, E. Gonzalez, C. Jimenez
Nephrology, Hospital Universitario La Paz, Madrid, Spain
*Purpose: BK virus infection represents one of the main viral infections within the first year after kidney transplantation, closely linked to the degree of immunosupresion.…
2019 American Transplant Congress
The Utility of Donor and Recipient BK Virus Antibody Testing Prior to Renal Transplantation in Risk Assessment for Developing BK Viremia
N. Donmez, S. I. Al-Akash
Driscoll Children's Hospital, Corpus Christi, TX
*Purpose: The correlation between donor (DON) and recipient (REC) BKV antibody (AB) titers and BK viremia in renal transplant (RTx) has not been well-studied in…
2019 American Transplant Congress
Characteristics of Patients with Early vs Late BK Viremia after Kidney Transplantation
S. Rehman¹, J. Pryor², A. Olyaei³, M. Stack¹, D. Norman¹, J. Lockridge¹
¹Medicine/Nephrology, Oregon Health and Science University, Portland, OR, ²Oregon Health and Science University, Portland, OR, ³Pharmacy, Oregon Health and Science University, Portland, OR
*Purpose: To describe the characteristics of patients presenting with late BK viremia (>1 year after transplant) and compare to early BK viremia*Methods: This study was…